S63845 is a selective MCL1 inhibitor that can selectively bind to the BH3-binding groove of MCL1, thereby effectively killing MCL1-dependent tumor cells, including MM, leukemia, and lymphoma cells [60]. This evidence concerns the gene MCL1 and leukemia.